Q3 Results: Emcure Pharma, Aptus Value Housing, Century Ply Report Strong Profit Growth

• Emcure Pharma's net profit surged by 50% year-on-year to ₹230.5 crore in Q3, with revenue up 20.4% to ₹2,363 crore.
• Aptus Value Housing Finance reported a 24% increase in net profit to ₹236 crore, driven by 23% revenue growth and stable asset quality.
• Century Plyboards saw its net profit rise by 9.4% to ₹64 crore, with revenue growing 18.4% to ₹1,350 crore and EBITDA up 32%.
• Emcure Pharma's shares gained 1.47% on NSE, reaching ₹1,528.30, following strong Q3 performance and investor buying.
• All three companies demonstrated improved operational efficiency, with Emcure Pharma's EBITDA margin at 20.8% and Century Ply's at 12.6%.